blosozumab binds sost negative regulator osteoblast activity blocking sost activity lead increased bone blosozaumab studied regards treatment osteoporosis men postmenopausal women clinical trials blosozumab shown antibody well tolerated effective producing bone anabolic blosozumab developed eli lilly company monoclonal article stub help wikipedia expanding drug article relating musculoskeletal system stub help wikipedia expanding httpsenwikipediaorgwikiblosozumab